AIDS合并活动性肺结核评分模型的建立与临床诊断价值 评估

doi:10.19871/j.cnki.xfcrbzz.2023.06.004

新发传染病电子杂志 ›› 2023, Vol. 8 ›› Issue (6): 22-26.doi: 10.19871/j.cnki.xfcrbzz.2023.06.004

AIDS合并活动性肺结核评分模型的建立与临床诊断价值评估

莫胜林¹, 黄云², 黄小红¹, 覃锦玉¹, 陈涛¹, 胡家光¹, 蒙达礼¹, 张鹏¹, 蒋忠胜¹, 孔晋亮³

1.广西医科大学附属柳州市人民医院感染性疾病科,广西柳州 545006;
2.广西科技大学附属卫生学校,广西柳州 545006;
3.广西医科大学一附院呼吸与危重症医学科,广西南宁 530021

收稿日期:2022-05-07 发布日期:2024-01-23
通讯作者: 孔晋亮,Email:kjl071@163.com
基金资助:
1.2021年国家临床重点专科建设项目（感染性疾病科）; 2.广西医药卫生科研课题（Z-B20221309,Z-B20221305,Z-B20221375）; 3.柳州市科技计划项目（2019BJ20601）; 4.柳州市科技计划项目（2021CBC0107）

Establishment and evaluation of a clinical diagnostic score model for AIDS complicated with active pulmonary tuberculosis

Mo Shenglin¹, Huang Yun², Huang Xiaohong¹, Qin Jinyu¹, Chen Tao¹, Hu Jiaguang¹, Meng Dali¹, Zhang Peng¹, Jiang Zhongsheng¹, Kong Jinliang³

1. Department of Infectious Diseases, Liuzhou People's Hospital, Guangxi Medical University, Guangxi Liuzhou545006, China;
2. Affiliated Health School, Guangxi University of Science and Technology, Guangxi Liuzhou 545006, China;
3. Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Guangxi Medical University, Guangxi Nanning 530021, China

Received:2022-05-07 Published:2024-01-23

摘要/Abstract

摘要： 目的建立AIDS合并活动性肺结核的评分模型,并对AIDS合并活动性肺结核的临床诊断价值进行评估。方法选取2014年10月1日至2021年9月30日在柳州市人民医院感染性疾病科住院的229例患者,其中AIDS合并活动性肺结核组104例,AIDS合并肺部非结核疾病组125例,对患者临床数据进行分析,以AIDS合并活动性肺结核组为结局指标进行单因素分析,单因素分析有意义的指标（P<0.05)作为自变量,进行多因素Logistic回归分析。根据多因素回归模型中的β回归系数进行赋值,建立临床诊断AIDS合并活动性肺结核的评分模型,并评估其对AIDS合并活动性肺结核的临床诊断预测能力。结果本临床诊断评分模型的6个变量分别为咳嗽、咳痰症状（7分）,CD4⁺T淋巴细胞数量（12分）,肺上叶病灶（6分）,多肺段病灶（7分）,肺部病灶并纵隔淋巴结肿大（7分）,单侧胸腔积液（6分）,总分45分。当分值大于24分时,临床诊断AIDS合并活动性肺结核时的曲线下面积为0.911（95%CI 0.864~0.958）（P<0.05）。敏感度和特异度分别为82.2%、92.0%。阳性预测值和阴性预测值分别为：89.6%、86.9%。验模组验证所得结果正确率达88.2%（60/68）。结论本研究建立的AIDS合并活动性肺结核的临床诊断评分模型在临床上使用操作简单易行,当CD4⁺T淋巴细胞数量≤200个/μl时,对AIDS合并活动性肺结核的临床诊断具有良好的预测能力。

关键词: AIDS, 活动性肺结核, 机会性感染, 临床诊断评分, CD4⁺T淋巴细胞

Abstract: Objective To establish a scoring model for the clinical diagnosis of active pulmonary tuberculosis in patients with AIDS using common clinical indicators and to evaluate the predictive performance of the model. Method A total of 229 patients admitted to the Department of Infectious Diseases, Liuzhou People's Hospital, from October 1, 2014, to September 30, 2021, were included in the study. Among them, there were 104 cases of AIDS combined with active pulmonary tuberculosis and 125 cases of AIDS combined with other non-tuberculous pulmonary diseases. Univariate analysis and binary logistic regression analysis were used to select variables favorable for diagnosing active pulmonary tuberculosis in AIDS patients. A clinical scoring model for the diagnosis of active pulmonary tuberculosis in AIDS was established, and the predictive ability of the model was assessed. Result In this clinical diagnostic scoring model, six variables were analyzed: cough and sputum symptoms (7 points), CD4⁺T lymphocyte count (12 points), upper lobe lung lesions (6 points), multi-segment lung lesions (7 points), lung lesions with mediastinal lymphadenopathy (7 points), and unilateral pleural effusion (6 points). When the score was greater than 24 points, the area under the curve for clinical diagnosis of active pulmonary tuberculosis in AIDS patients was 0.911 (95%CI 0.864-0.958) (P<0.05). The sensitivity and specificity were 82.2% and 92.0%, respectively. The positive predictive value and negative predictive value were 89.6% and 86.9%, respectively. The results obtained from the validation group achieved an accuracy of 88.2% (60/68). Conclusion The clinical diagnostic scoring model for active pulmonary tuberculosis in AIDS patients established in this study is simple to use in clinical practice and has good predictive and pre-judgment efficacy for evaluating whether HIV-infected individuals with a CD4⁺T lymphocyte count ≤200/μl are combined with active pulmonary tuberculosis.

Key words: Acquired immune deficiency syndrome, Active pulmonary tuberculosis, Opportunistic infection, Clinical diagnostic score, CD4⁺T lymphocyte

中图分类号:

R521

莫胜林, 黄云, 黄小红, 覃锦玉, 陈涛, 胡家光, 蒙达礼, 张鹏, 蒋忠胜, 孔晋亮. AIDS合并活动性肺结核评分模型的建立与临床诊断价值评估[J]. 新发传染病电子杂志, 2023, 8(6): 22-26.

Mo Shenglin, Huang Yun, Huang Xiaohong, Qin Jinyu, Chen Tao, Hu Jiaguang, Meng Dali, Zhang Peng, Jiang Zhongsheng, Kong Jinliang. Establishment and evaluation of a clinical diagnostic score model for AIDS complicated with active pulmonary tuberculosis[J]. Electronic Journal of Emerging Infectious Diseases, 2023, 8(6): 22-26.

参考文献

[1] 中华医学会感染病学分会AIDS丙型肝炎学组, 中国疾病预防与控制中心.中国AIDS诊疗指南(2018版)[J/CD].新发传染病电子杂志,2019,4(2):65-84.
[2] 中华医学会感染病学分会AIDS学组.HIV合并结核分枝杆菌感染诊治专家共识[J]. 中华临床感染病杂志, 2017, 10(2):81-90.
[3] 中华人民共和国国家卫生和计划生育委员会.肺结核诊断标准(WS 288—2017)[J/CD].新发传染病电子杂志,2018,3(1):59-61.
[4] DAY JH, GRANT AD, FIELDING KL, et al.Does tuberculosis increase HIV load[J]. J Infect Dis, 2004, 190(9):1677-1684.
[5] 张丽霞, 谢伟, 孙昕. GeneXpert MTB/RIF检测技术在AIDS合并肺结核双重感染的诊断价值[J].中华检验医学杂志, 2016, 39(1):53-54.
[6] LOPEZ GH, COLE SR, MARGOLICK JB, et al.Effect of tuberculosis on the survival of HIV-infected men in a country with low tuberculosis incidence[J]. AIDS, 2008, 22(14): 1869-1873.
[7] ZHANG WS, ZHANG WW, WANG W.Analyzing the epidemic of tuberculosis and HIV co-infection from 2007-2015 in Urumqi[J]. Mod Prevent Med, 2017, 44(10):1867-1870.
[8] 王青, 夏俊, 罗泽斌. AIDS合并肺结核的临床及影像学特征的研究进展[J].医学综述,2013, 19(7):1284-1286.
[9] 沈银忠, 卢洪洲.AIDS合并结核病诊治现状[J].中国实用内科杂志,2015, 35(8): 671-674.
[10] RANSOHOFF RM, KIVISAKK P, KIDD G.Three or more routes for leukocyte migration into the central nervous system[J]. Nat Rev Immunol, 2003, 3(7):569-581.
[11] KARUNARATNE AH, GAMLATH PM, UDITHANI LC, et al.Impact of tuberculosis and long term benefits of anti-retroviral treatment in patients with HIV in Sri Lanka[J]. Ceylon Med J, 2018, 63(8):143-148.
[12] GODFREY FP, MAHER D, MUKADI YD, et al.How human immunodeficiency virus voluntary testing can contribute to tuberculosis control[J]. IAPAC Mon, 2003, 9(3): 54-60.
[13] KANG OC, HARRIES AD, BANDA H, et al.High mortality rates in tuberculosis patients in Zomba Hospital,Malawi, during 32 months of follow up[J]. Trans R Soc Trop Med Hyg, 2000, 94(20):305-309.
[14] PEPPER DJ, SCHOMAKER M, WILKINSON RJ, et al.Independent predictors of tuberculosis mortality in a high HIV prevalence setting: a retrospective cohort study[J].AIDS Res Ther, 2015, 12(6):35.
[15] HARRIES AD, ZACHARIAH R, CORBETT EL, et al.The HIV-associated tuberculosis epidemic-When will we act[J].Lancet, 2010, 375(9729):1906-1919.
[16] HORSBURGH CJ.Priorities for the treatment of latent tuberculosis infection in the United States[J]. N Engl J Med, 2004, 350(23):2060-2067.
[17] VAN DSM, SCHIM VDLM, BENNETT RC, et al.Incidence of tuberculosis and survival after its diagnosis in patients infected with HIV-1 and HIV-2[J]. AIDS, 2004, 18(14):1933-1941.
[18] WHALEN CC, ZALWANGO S, CHIUNDA A, et al.Secondary attack rate of tuberculosis in urban households in Kampala,Uganda[J]. PLoS One, 2011, 6(2):e16137.
[19] 中国性病AIDS防治协会HIV合并结核病专业委员会.人类免疫缺陷病毒感染/AIDS合并结核分枝杆菌感染诊治专家共识[J/CD].新发传染病电子杂志,2022, 7(1):73-87.
[20] CHAN CK,WONG KH,LEE MP,et al.Risk factors associated with 1-year mortality among patients with HIV-associated tuberculosis in areas with intermediate tuberculosis burden and low HIV prevalence[J]. Hong Kong Med J, 2018, 24(5):473-483.
[21] TOLA A, MISHORE KM, AYELE Y, et al.Treatment outcome of tuberculosis and associated factors among TB-HIV coinfected patients at public hospitals of Harar Town, Eastern Ethiopia. A five-year retrospective study[J]. BMC Public Health, 2019, 19(1):1658.
[22] 刘晓宁, 范晓云.HIV/AIDS合并肺结核与单纯肺结核的临床特征比较及治疗效果分析[J].实用医学杂志, 2017, 33(22):3780-3784.
[23] 李春华, 吕圣秀, 舒伟强, 等. 获得性免疫缺陷综合征合并肺结核与正常免疫肺结核的CT表现[J].中国医学影像学杂志, 2015, 23(12):924-928.
[24] 覃江龙,梁纲,卢祥婵,等.AIDS合并肺结核和(或)马尔尼菲蓝状菌病的影像学研究[J/CD].新发传染病电子杂志,2018,3(3):171-174.
[25] 舒伟强, 吕圣秀, 李春华, 等.AIDS并发肺结核多层螺旋CT影像特点分析[J].临床肺科杂志, 2019, 24(10):1891-1895.
[26] 于晓敏, 许乙凯. AIDS合并肺结核CD4+T细胞、病原菌分布及其CT影像学检查结果分析[J].临床肺科杂志, 2019, 24(2):195-198.
[27] 任荣, 程晰, 刘荣荣, 等. AIDS合并粟粒性肺结核的CT影像与CD4+T淋巴细胞低下程度的相关分析[J/CD].新发传染病电子杂志, 2021, 6(3):242-246.

AIDS合并活动性肺结核评分模型的建立与临床诊断价值评估

Establishment and evaluation of a clinical diagnostic score model for AIDS complicated with active pulmonary tuberculosis

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 10

编辑推荐

Metrics

本文评价

[1]	郑宏, 秦志华, 陈晓丽, 明湘虹, 袁瑛. 基于临床指标构建的列线图模型评分对活动性肺结核与非活动性肺结核的诊断价值[J]. 新发传染病电子杂志, 2023, 8(5): 11-15.
[2]	何庆军, 姚文艳, 校丹, 李红兵, 吴水淼. 慢性阻塞性肺疾病合并活动性肺结核患者血清细胞因子表达水平及其与疾病的相关性[J]. 新发传染病电子杂志, 2023, 8(4): 15-19.
[3]	邹薇, 邬小萍, 陈新萍, 刘梨, 邹世杰, John Foster, J. Victor Garcia. 猿猴免疫缺陷病毒_大猩猩具有跨物种以及在人群中传播的能力[J]. 新发传染病电子杂志, 2023, 8(3): 1-6.
[4]	任荣, 程晰, 刘荣荣, 袁功玲, 刘静, 姚文妍, 李敏. 艾滋病合并粟粒性肺结核的CT影像与CD4⁺T淋巴细胞低下程度的相关分析[J]. 新发传染病电子杂志, 2021, 6(3): 242-246.
[5]	钟平. HIV分子流行病学研究和实践进展[J]. 新发传染病电子杂志, 2019, 4(3): 137-144.
[6]	袁婧, 李春华, 李奇穗, 余庆, 吕圣秀, 陈耀凯. 严重免疫缺陷时HIV/TB合并感染者胸部CT表现与CD4⁺T淋巴细胞计数水平的相关性研究[J]. 新发传染病电子杂志, 2019, 4(3): 145-148.
[7]	刘德纯, 李宏军. 艾滋病与艾滋病毒感染者48例临床影像与病理分析[J]. 新发传染病电子杂志, 2019, 4(3): 152-155.
[8]	马景旭, 杨豫新, 刘莹, 郝璐, 褚相乐, 王红. 磁共振DTI成像技术在艾滋病合并脑内结核和弓形虫感染中的应用价值[J]. 新发传染病电子杂志, 2019, 4(1): 15-19.
[9]	袁虹. 艾滋病合并脑内寄生虫感染的临床及影像表现[J]. 新发传染病电子杂志, 2018, 3(4): 239-243.
[10]	覃江龙, 梁纲, 卢祥婵, 张剑锋, 宁宗, 卢亦波, 吴念宁, 吴锋耀. 艾滋病合并肺结核和（或）马尔尼菲蓝状菌病的影像学研究[J]. 新发传染病电子杂志, 2018, 3(3): 171-174.

AIDS合并活动性肺结核评分模型的建立与临床诊断价值 评估

Establishment and evaluation of a clinical diagnostic score model for AIDS complicated with active pulmonary tuberculosis

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 10

编辑推荐

Metrics

本文评价

AIDS合并活动性肺结核评分模型的建立与临床诊断价值评估